1 – 10 of 2258
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- Toxin-Based Rodent Models of Parkinson’s Disease
-
Associations of Plasma Phospho-Tau217 Levels with Tau Positron Emission Tomography in Early Alzheimer Disease
Janelidze, Shorena LU ; Berron, David LU ; Smith, Ruben LU ; Strandberg, Olof LU ; Proctor, Nicholas K. ; Dage, Jeffrey L. ; Stomrud, Erik LU ; Palmqvist, Sebastian LU
; Mattsson-Carlgren, Niklas
LU
and Hansson, Oskar
LU
(2021)
In JAMA Neurology
78(2).
p.149-149
Mark
- The role of cortico-basal ganglia systems in the construction of movement: Action selection and sequencing
- A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
-
Grafts Derived from an α-Synuclein Triplication Patient Mediate Functional Recovery but Develop Disease-Associated Pathology in the 6-OHDA Model of Parkinson's Disease
Shrigley, Shelby LU
; Nilsson, Fredrik
LU
; Mattsson, Bengt
LU
; Fiorenzano, Alessandro
LU
; Mudannayake, Janitha
LU
; Bruzelius, Andreas
LU
; Ottosson, Daniella Rylander
LU
; Björklund, Anders
LU
; Hoban, Deirdre B
LU
and Parmar, Malin
LU
(2021)
In Journal of Parkinson's Disease
11(2).
p.515-528
Mark
- Hippocampal subfield volumetry from structural isotropic 1 mm3 MRI scans : A note of caution
- The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease
- Mesial temporal tau is related to worse cognitive performance and greater neocortical tau load in amyloid-β–negative cognitively normal individuals
- A stress syndrome prototype reflects type 3 diabetes and ischemic stroke risk : The SABPA study
- Glymphatic pathways in the gyrencephalic brain